Medline refinances term loan with new USD 2.75 billion facility due 2033
Medline
Medline MDLN | 0.00 |
- Medline entered a refinancing package dated May 28, 2026, including a new USD 2.75 billion senior secured term loan facility maturing May 28, 2033.
- The facility refinanced the existing dollar term loan due 2030; loans amortize 1% annually with the remaining balance due at maturity.
- Pricing set at an applicable margin over a base rate or Term SOFR, subject to a 0.5% Term SOFR floor.
- Proceeds from the broader refinancing repaid the term loan due 2028, refinanced about USD 724 million of the 2030 facility, redeemed about USD 500 million of 6.25% senior secured notes due 2029.
- Voluntary prepayments tied to certain repricing transactions within six months trigger a 1% premium, subject to exceptions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medline Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-252557), on June 02, 2026, and is solely responsible for the information contained therein.
